Tuesday, July 29, 2008
Ambrilia says partner Merck & Co is suspending development of HIV drug
MONTREAL - Ambrilia Biopharma Inc. said Monday that partner Merck & Co Inc. has decided to suspend development of the HIV drug MK-8122....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment